decisionhealth Newsletters, Part B News - 2006 Issue 9 (September)
Cancer docs seek separate reimbursement
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare reimbursement policy issue affecting oncology practices and cancer drug payments. It summarizes advocacy efforts around federal legislation, references an existing demonstration payment model, and explains why the issue matters to cancer providers and their patients. The piece is relevant to oncologists, practice managers, coders, and reimbursement professionals following legislative and payment policy changes.
Why This Topic Matters
It highlights a pending shift in oncology reimbursement that could affect how cancer care services and drugs are paid under Medicare and related federal policy initiatives.
What You Will Learn
- The general Medicare reimbursement issue affecting oncology practices
- The role of federal legislation in proposed payment changes
- How demonstration payment programs can influence oncology reimbursement policy
- Why pending congressional action matters to cancer providers
Who Should Read This
- Oncologists
- Cancer center administrators
- Medical coders
- Billing and reimbursement staff
- Health policy professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com